
|Articles|June 10, 2016
Oncology Drug Success Rate Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/oncology-drug-success-rate-highlights-specialty-ph" target="_blank">View the story "Oncology Drug Success Rate Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role
2
Improving Outcomes in Diffuse B-Cell Lymphoma Requires Multidisciplinary Evolution
3
Daratumumab Boosts Depth and Durability of Response After ASCT, Offering Clear Guidance for Pharmacist Counseling
4
Long Term BENEFIT Data Affirm Isa-VRd as Standard of Care in Transplant-Ineligible NDMM
5
















































































































































































































